Biogen (BIIB) Non-Current Assets (2009 - 2026)

Biogen has reported Non-Current Assets for 18 years, with the latest figure at $24.8 billion in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 21.7% year-over-year to $24.8 billion in Q2 2026; TTM through Jun 2026 was $85.8 billion, a 3.58% increase from a year earlier, with the FY2025 full-year figure at $20.5 billion, down 0.62% from the prior year.
• Non-Current Assets was $24.8 billion for Q2 2026 at Biogen, up from $20.3 billion in the prior quarter.
• The five-year high for Non-Current Assets was $24.8 billion in Q2 2026, with the low at $14.7 billion in Q2 2023.
• Average Non-Current Assets over 5 years is $18.8 billion, with a median of $19.9 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets decreased 11.26% in 2022, then surged 35.38% in 2023.
• Over 5 years, Non-Current Assets stood at $14.8 billion in 2022, then soared by 35.38% to $20.0 billion in 2023, then rose by 3.04% to $20.6 billion in 2024, then declined by 0.62% to $20.5 billion in 2025, then advanced by 21.09% to $24.8 billion in 2026.
• The last three Non-Current Assets figures came in at $24.8 billion (Q2 2026), $20.3 billion (Q1 2026), and $20.5 billion (Q4 2025), per Business Quant data.